Continuation Funds Stormed the Alts World, But Are They Performing?
Private fund managers are on track for yet another record tally of continuation fund formation –the fifth year running in a trend that took off in 2020 and has kept up through market highs and lows. But even as the 2025 count appears set to top last year's 65 deals and $27.3 billion in volume, a key statistic for the market remains elusive: how exactly the current crop of continuation vehicles is performing.
A&M's Transaction Advisory Group Managing Director Anthony Caporrino was recently featured in FundFire's article, highlighting the goal of continuation vehicle performance to mimic buyout strategies and other private funds, stating, "most astute limited partners would expect those types of returns, but there isn't a ton of data to measure because of the short history here."
Caporrino emphasizes the potential for these vehicles to perform in line with the broader private equity market, adding that as the economy strengthens and interest rates decline, performance is likely to improve. Caporrino also points out that early data should be cautiously interpreted, as it is largely based on manager-generated valuations with few actual exits from early continuation funds.
Read the full article
Infrastructure Pulse Survey Report: Spring 2026, North America and Europe
May 14, 2026
The Infrastructure Pulse Survey Report for Spring 2026, published by Alvarez & Marsal in collaboration with the Global Infrastructure Investor Association (GIIA), offers an insight into how investors across North America and Europe are reading the current investment landscape through a period of macroeconomic and geopolitical uncertainty.
Alvarez & Marsal Continues to Strengthen Transaction Advisory Practice in Australia with Senior Talent
May 13, 2026
Alvarez & Marsal (A&M), a leading global professional services firm, today announced the appointment of Sydney-based Roshan Emmanuel as a Managing Director within its Global Transaction Advisory Group (Global TAG), underscoring the firm’s rapid growth and continued investment in the Australian market.
Carving Out Success: Life Sciences Companies Are Rationalizing Portfolios by Divesting Non-Core Assets
May 12, 2026
Historically, large healthcare and life sciences corporations have focused deal activity on a breadth of diverse assets. However, the landscape is undergoing significant transformation as businesses shift to rationalize their portfolios and invest in fewer core areas.
Alvarez & Marsal’s Global Transaction Advisory Group Continues to Expand Senior Talent Ranks in Europe
May 6, 2026
The practice welcomes new Managing Directors Tobias Ranker and Eric Poitevin to support growth in Germany and France